Hepatic Arterioportal Fistula Is Associated with Decreased Future Liver Remnant Regeneration after Stage-I ALPPS for Hepatocellular Carcinoma
Background Hepatocellular carcinoma (HCC) patients often developed hepatic arterioportal fistula (APF). The aim of this study is to evaluate the impact of APF on future liver remnant (FLR) regeneration and surgical outcomes after the first stage of associating liver partition and portal vein ligation for staged hepatectomy (stage-I ALPPS). Methods Consecutive HCC patients who underwent ALPPS at our center between March 2017 and May 2019 were retrospectively studied. Data for the association between APF and clinicopathological details, liver volume, and surgical outcomes were analyzed. Results The enrolled 35 HCC patients were divided into three groups: 15 patients with preoperative APF were classified as the APF I group, 10 patients developed APF after stage-I ALPPS as the APF II group, whereas the other 10 patients without APF before and after stage-I ALPPS as the control group. After stage-I ALPPS, patients in the APF I and APF II groups had lower kinetic growth rate (KGR) of FLR volume (6.1±3.2%, 11.4±8.4%, 25.0±8.8% per week, respectively, P<0.001) and took longer median time to reach the sufficient FLR volume for stage-II ALPPS (17.5 days, 12 days, 6 days, respectively, P<0.001) than those in the control group. Meanwhile, the incidence of posthepatectomy liver failure (PHLF) in the APF I and APF II groups was significantly higher than that of the control group (P=0.007). There are 27 (77.1%) patients who completed stage-II ALPPS. The overall survival (OS) rates at 1 and 3 years were 59.3% and 35.1%, whereas the disease-free survival (DFS) rates at 1 and 3 years were 44.4% and 22.9%, respectively. Conclusions Hepatic APF is significantly associated with decreased FLR regeneration and a higher risk of PHLF after stage-I ALPPS. HCC patients who are to undergo ALPPS may benefit from the timely perioperative intervention of APF..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Journal of gastrointestinal surgery - 25(2021), 9 vom: 07. Mai, Seite 2280-2288 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ye, Chunhui [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
ALPPS |
|---|
| Anmerkungen: |
© The Society for Surgery of the Alimentary Tract 2021 |
|---|
| doi: |
10.1007/s11605-021-05022-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2077081198 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2077081198 | ||
| 003 | DE-627 | ||
| 005 | 20230512182429.0 | ||
| 007 | tu | ||
| 008 | 221220s2021 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11605-021-05022-0 |2 doi | |
| 035 | |a (DE-627)OLC2077081198 | ||
| 035 | |a (DE-He213)s11605-021-05022-0-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Ye, Chunhui |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hepatic Arterioportal Fistula Is Associated with Decreased Future Liver Remnant Regeneration after Stage-I ALPPS for Hepatocellular Carcinoma |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Society for Surgery of the Alimentary Tract 2021 | ||
| 520 | |a Background Hepatocellular carcinoma (HCC) patients often developed hepatic arterioportal fistula (APF). The aim of this study is to evaluate the impact of APF on future liver remnant (FLR) regeneration and surgical outcomes after the first stage of associating liver partition and portal vein ligation for staged hepatectomy (stage-I ALPPS). Methods Consecutive HCC patients who underwent ALPPS at our center between March 2017 and May 2019 were retrospectively studied. Data for the association between APF and clinicopathological details, liver volume, and surgical outcomes were analyzed. Results The enrolled 35 HCC patients were divided into three groups: 15 patients with preoperative APF were classified as the APF I group, 10 patients developed APF after stage-I ALPPS as the APF II group, whereas the other 10 patients without APF before and after stage-I ALPPS as the control group. After stage-I ALPPS, patients in the APF I and APF II groups had lower kinetic growth rate (KGR) of FLR volume (6.1±3.2%, 11.4±8.4%, 25.0±8.8% per week, respectively, P<0.001) and took longer median time to reach the sufficient FLR volume for stage-II ALPPS (17.5 days, 12 days, 6 days, respectively, P<0.001) than those in the control group. Meanwhile, the incidence of posthepatectomy liver failure (PHLF) in the APF I and APF II groups was significantly higher than that of the control group (P=0.007). There are 27 (77.1%) patients who completed stage-II ALPPS. The overall survival (OS) rates at 1 and 3 years were 59.3% and 35.1%, whereas the disease-free survival (DFS) rates at 1 and 3 years were 44.4% and 22.9%, respectively. Conclusions Hepatic APF is significantly associated with decreased FLR regeneration and a higher risk of PHLF after stage-I ALPPS. HCC patients who are to undergo ALPPS may benefit from the timely perioperative intervention of APF. | ||
| 650 | 4 | |a Hepatic arterioportal fistula | |
| 650 | 4 | |a Hepatocellular carcinoma | |
| 650 | 4 | |a ALPPS | |
| 650 | 4 | |a Future liver remnant | |
| 650 | 4 | |a Regeneration | |
| 650 | 4 | |a Posthepatectomy liver failure | |
| 700 | 1 | |a Zhang, Ling |4 aut | |
| 700 | 1 | |a Xu, Banghao |4 aut | |
| 700 | 1 | |a Li, Jian |4 aut | |
| 700 | 1 | |a Lu, Tingting |4 aut | |
| 700 | 1 | |a Zeng, Jingjing |4 aut | |
| 700 | 1 | |a Guo, Ya |4 aut | |
| 700 | 1 | |a Peng, Minhao |4 aut | |
| 700 | 1 | |a Bao, Li |4 aut | |
| 700 | 1 | |a Wen, Zhang |4 aut | |
| 700 | 1 | |a Wang, Jilong |0 (orcid)0000-0002-6798-2227 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of gastrointestinal surgery |d Springer US, 1997 |g 25(2021), 9 vom: 07. Mai, Seite 2280-2288 |w (DE-627)320502201 |w (DE-600)2012365-6 |w (DE-576)091140536 |x 1091-255X |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2021 |g number:9 |g day:07 |g month:05 |g pages:2280-2288 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11605-021-05022-0 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2021 |e 9 |b 07 |c 05 |h 2280-2288 | ||